Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cells

被引:7
|
作者
Kim, Jongdoo [1 ]
Lee, Jihyun [1 ,2 ]
Kim, Ukjin [1 ]
Park, Jong-Kuk [1 ]
Um, Hong-Duck [1 ]
机构
[1] Korea Inst Radiol & Med Sci, Div Radiat Biomed Res, 75 Nowon Ro, Seoul 01812, South Korea
[2] Seoul Natl Univ, Korea Mouse Phenotyping Ctr, Seoul 08826, South Korea
基金
新加坡国家研究基金会;
关键词
p53; p21; zinc finger protein SNAI2; Mdm2; protein stability; tumor suppressor; oncogene; RING-FINGER DOMAIN; P21(WAF1/CIP1); INVASION; NUCLEAR; SNAIL; ACTIVATION; REGULATOR; ONCOGENE;
D O I
10.3892/ol.2021.12942
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our previous study revealed that the tumor suppressor/transcription factor p53 directly binds to its transcriptional target, p21, and that the p53/p21 complex binds to zinc finger protein SNAI2 (Slug), a tumor promoter/transcription factor; thereby promoting the degradation of Slug by Mdm2, an E3 ligase. The present study demonstrated that Slug reduced the cellular expression levels of p53 and p21 in HCT116 colon cancer by decreasing their protein stability. In parallel, Slug increased the mRNA and protein expression levels of Mdm2 in these cells. Moreover, knockdown of Mdm2 using specific small interfering RNAs abolished the ability of Slug to induce the degradation of p53 and p21. Considering the well-known function of Mdm2 in facilitating p53 and p21 degradation, these data suggested that Slug promoted p53 and p21 degradation by inducing Mdm2 expression. Moreover, Slug increased ubiquitination levels of p53 in HCT116 cells. This is consistent with the fact that Mdm2 induces p53 degradation by ubiquitinating p53, and further confirmed that Mdm2 acted downstream of Slug. Comparative studies using HCT116 cells and their p53- or p21-knockout variants have revealed that Slug requires p21 to induce p53 degradation. This result is consistent with our previous study, which revealed that Mdm2 acts more efficiently on p53 in the p53/p21 complex compared with on p53 alone. By contrast, Slug did not require p53 to induce p21 degradation, suggesting that p53 was dispensable in Mdm2-mediated p21 degradation. Notably, the ability of Slug to increase/decrease Mdm2/p53 and p21 levels, respectively, was not confined to HCT116 cells alone, but was also confirmed in A549 and H460 lung cancer cells. Collectively, the results of the present study suggested that Slug could counter p53 and p21. The balance between these two opposing groups (Slug vs. p53/p21) may depend on environmental stresses and the internal physiology of cells.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Influence of p21 and p53 on HDAC-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo
    Ocker, Matthias
    Zopf, Steffen
    Neureiter, Daniel
    Ganslmayer, Marion
    Hahn, Eckhart G.
    Herold, Christoph
    GASTROENTEROLOGY, 2006, 130 (04) : A530 - A530
  • [2] Hinokiflavone, as a MDM2 inhibitor, activates p53 signaling pathway to induce apoptosis in human colon cancer HCT116 cells
    Zhang, Siyu
    Wang, Yifan
    Sun, Yujie
    Zhao, Guangjian
    Wang, Juan
    Liu, Lu
    Liu, Fang
    Wang, Peng
    Yang, Jinbo
    Xu, Ximing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 594 : 93 - 100
  • [3] Regulation of p53 stability and function in HCT116 colon cancer cells
    Kaeser, MD
    Pebernard, S
    Iggo, RD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) : 7598 - 7605
  • [4] Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo
    Zopf, Steffen
    Neureiter, Daniel
    Bouralexis, Steve
    Abt, Tobias
    Glaser, Keith B.
    Okamoto, Kinya
    Ganslmayer, Marion
    Hahn, Eckhart G.
    Herold, Christoph
    Ocker, Matthias
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (06) : 1391 - 1402
  • [5] Mdm2 promotes the rapid degradation of p53
    Ygal Haupt
    Ruth Maya
    Anat Kazaz
    Moshe Oren
    Nature, 1997, 387 : 296 - 299
  • [6] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    NATURE, 1997, 387 (6630) : 296 - 299
  • [7] Variations in the expression of p53 and downstream target genes p21 and MDM2 in breast cancer treatment
    Ziyaie, D
    Hupp, TR
    Kernohan, NM
    Ingram, A
    Thompson, AM
    BRITISH JOURNAL OF CANCER, 2002, 86 : S76 - S76
  • [8] Colon cancer HCT116 cells deficient in p21/Cip1 are hypersensitive to tyrosine kinase inhibitors imatinib and gefitinib through a mechanism unrelated to p21 and dependent on p53 hyperactivity
    Ferrandiz, Nuria
    Martin-Perez, Jorge
    Blanco, Rosa
    Donertas, Derya
    Weber, Axel
    Paolo, Dotto
    Eilers, Martin
    Delgado, M. Dolores
    Leon, Javier
    CANCER RESEARCH, 2009, 69
  • [9] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [10] Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland
    Freire Soares Marques, Yonara Maria
    Moura de Lima, Marina de Deus
    Alves, Sergio de Melo
    Soares, Fernando Augusto
    de Araujo, Vera Cavalcanti
    Pinto, Decio dos Santos
    Mantesso, Andrea
    ORAL ONCOLOGY, 2008, 44 (09) : 903 - 908